Global Topotecan Market Size, by Product Type (Capsules), by Application (Ovarian Cancer), by End User (Hospitals) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1261474
  • |
  • Publishe Date : September 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

Topotecan is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types.

The Global Topotecan Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Prevalence of cancer with selected treatment course is the key driver for the market. However, association of side effects with drugs may become barrier to the market growth in the forecast period.

The global Topotecan market is primarily segmented based on different product type, application, end user and region. On the basis product type, market is segmented into capsules injection. On the basis of application, market is segmented into ultra-lung cancer, lung cancer, cosmetics and others. On the basis of end user, market is segmented into hospitals, clinics and ambulatory surgical centers. On the basis of regions, market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

On the basis of product type, the market is split into:
* Capsules
* Injection

On the basis of application, the market is split into:
* Ovarian Cancer
* Lung Cancer
* Others

On the basis of end user, the market is split into:
* Hospitals
* Clinics
* Ambulatory Surgical Centers

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* GlaxoSmithKline plc.
* Mylan N.V.
* Fresenius Kabi
* Cipla
* Sagent Pharmaceuticals
* Teva
* Dr. Reddy’s Laboratories
* Pfizer
* Accord-UK Ltd.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, product type, application and end user market size and their forecast from 2018-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions product type, application and end user with qualitative and quantitative information and facts

Target Audience:
* Topotecan Manufactures
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research follows by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Topotecan Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Topotecan Market - Porter\'s Five Forces Analysis
4.4. Global Topotecan Market - PESTEL Analysis

5. Global Topotecan Market, by Product Type
5.1. Global Topotecan Market, Size and Forecast, 2015-2026
5.2. Global Topotecan Market, by Capsules, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Topotecan Market, by Injection, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026

6. Global Topotecan Market, by Application
6.1. Global Topotecan Market, Size and Forecast, 2015-2026
6.2. Global Topotecan Market, by Ovarian Cancer, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Topotecan Market, by Lung Cancer, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Topotecan Market, by Others, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026

7. Global Topotecan Market, by End User
7.1. Global Topotecan Market, Size and Forecast, 2015-2026
7.2. Global Topotecan Market, by Hospitals, 2015-2026
7.2.1. Key driving factors, trends and opportunities
7.2.2. Market size and forecast, 2015-2026
7.3. Global Topotecan Market, by Clinics, 2015-2026
7.3.1. Key driving factors, trends and opportunities
7.3.2. Market size and forecast, 2015-2026
7.4. Global Topotecan Market, by Ambulatory Surgical Center, 2015-2026
7.4.1. Key driving factors, trends and opportunities
7.4.2. Market size and forecast, 2015-2026

8. Global Topotecan Market by Region
8.1. Topotecan Market Regional Analysis, 2015-2026
8.2. Global Topotecan Market Revenue (USD Million) by Region, 2015-2026
8.3. North America Topotecan Market, 2015-2026
8.3.1. North America Topotecan Market Size and Forecast, 2015-2026
8.3.2. North America Topotecan Market by Country, 2015-2026
8.3.2.1. U.S. Topotecan Market, 2015-2026
8.3.2.2. Canada Topotecan Market, 2015-2026
8.4. Europe Topotecan Market, 2015-2026
8.4.1. Europe Topotecan Market Size and Forecast, 2015-2026
8.4.2. Europe Topotecan Market by Country, 2015-2026
8.4.2.1. Germany Topotecan Market, 2015-2026
8.4.2.2. France Topotecan Market, 2015-2026
8.4.2.3. Italy Topotecan Market, 2015-2026
8.4.2.4. UK Topotecan Market, 2015-2026
8.4.2.5. Spain Topotecan Market, 2015-2026
8.4.2.6. Rest of Europe Topotecan Market, 2015-2026
8.5. Asia Pacific Topotecan Market, 2015-2026
8.5.1. Asia Pacific Topotecan Market Size and Forecast, 2015-2026
8.5.2. Asia Pacific Topotecan Market by Country, 2015-2026
8.5.2.1. Japan Topotecan Market, 2015-2026
8.5.2.2. China Topotecan Market, 2015-2026
8.5.2.3. India Topotecan Market, 2015-2026
8.5.2.4. Rest of Asia Pacific Topotecan Market, 2015-2026
8.6. South America Topotecan Market, 2015-2026
8.6.1. South America Topotecan Market Size and Forecast, 2015-2026
8.6.2. South America Topotecan Market by Country, 2015-2026
8.6.2.1. Mexico Topotecan Market, 2015-2026
8.6.2.2. Brazil Topotecan Market, 2015-2026
8.6.2.3. Rest of South America Topotecan Market, 2015-2026
8.7. Middle East & Africa Topotecan Market, 2015-2026
8.7.1. Middle East & Africa Topotecan Market Size and Forecast, 2015-2026
8.7.2. Middle East & Africa Topotecan Market by Country, 2015-2026
8.7.2.1. Saudi Arabia Topotecan Market, 2015-2026
8.7.2.2. South Africa Topotecan Market, 2015-2026
8.7.2.3. Rest of Middle East & Africa Topotecan Market, 2015-2026

9. Competitive Landscape
9.1. Introduction
9.2. Market Share Analysis/Top Player Positioning, 2018

10. Company Profiles
10.1. GlaxoSmithKline plc.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Product Benchmarking
10.1.4. Key Developments
10.2. Mylan N.V.
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Product Benchmarking
10.2.4. Key Developments
10.3. Fresenius Kabi
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Product Benchmarking
10.3.4. Key Developments
10.4. Cipla
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Product Benchmarking
10.4.4. Key Developments
10.5. Sagent Pharmaceuticals
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Product Benchmarking
10.5.4. Key Developments
10.6. Teva
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Product Benchmarking
10.6.4. Key Developments
10.7. Dr. Reddy\'s Laboratories
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Product Benchmarking
10.7.4. Key Developments
10.8. Pfizer
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Product Benchmarking
10.8.4. Key Developments
10.9. Accord-UK Ltd.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Product Benchmarking
10.9.4. Key Developments

11. Key Insights

Content are not available

Choose License Type